Abrogation of the biological activity of the CFU-S inhibitor AcSDKP by a polyclonal antiserum.
Lauret
E
E
Inserm U.250, Institut Gustave-Roussy, Villejuif, France.
Miyanomae
T
T
Troalen
F
F
Sotty
D
D
Frindel
E
E
D000818:Animals; D005260:Female; D006412:Hematopoietic Stem Cells / Q000187:drug effects*; D007106:Immune Sera / Q000276:immunology*; D008297:Male; D051379:Mice; D008808:Mice, Inbred CBA; D009842:Oligopeptides / Q000276:immunology* / Q000494:pharmacology; D011817:Rabbits
D007106:Immune Sera; D009842:Oligopeptides; C058504:goralatide